Scarica l'app Stockscreener
0.4155
4.28%
-0.0186
Dopo l'orario di chiusura:
.42
0.0045
+1.08%
Intensity Therapeutics Inc Borsa (INTS) Ultime notizie
Why Intensity Therapeutics Inc. stock is rated strong buyLightweight Speed Options & trail grip notes for mixed terrain - ulpravda.ru
Can Intensity Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Analyst Calls & Precise Entry and Exit Recommendations - ulpravda.ru
Should I hold or sell Intensity Therapeutics Inc. stock in 20252025 Technical Patterns & Low Risk High Reward Ideas - ulpravda.ru
What insider trading reveals about Intensity Therapeutics Inc. stockPortfolio Value Report & Long-Term Safe Investment Ideas - ulpravda.ru
Can Intensity Therapeutics Inc. stock attract ESG capital inflowsShort Setup & Technical Pattern Alert System - ulpravda.ru
Can VMS Industries Limited Achieve Earnings Growth in a SlowdownPrice Support Zones & Free Tap Rapid Wealth - earlytimes.in
Pullback Watch: Why Intensity Therapeutics Inc. stock appeals to analysts2025 Geopolitical Influence & Safe Entry Point Alerts - moha.gov.vn
Intensity Therapeutics plunges on $2.35M public offering - MSN
Intensity Therapeutics receives 180-day Nasdaq extension to regain compliance - MSN
Intensity Therapeutics (INTS) Stock Price, Quote, News & History - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Why Intensity Therapeutics Inc. stock appeals to analystsJuly 2025 Sentiment & Daily Profit Maximizing Tips - Улправда
Why Intensity Therapeutics Inc. stock is a must watch in 2025July 2025 Analyst Calls & Weekly High Conviction Ideas - Улправда
Can Intensity Therapeutics Inc. stock double in next 5 years2025 Fundamental Recap & Weekly Breakout Watchlists - Улправда
CEO Change: Can Intensity Therapeutics Inc. stock attract ESG capital inflows2025 Risk Factors & Precise Buy Zone Identification - moha.gov.vn
How Intensity Therapeutics Inc. stock performs in high volatility marketsJuly 2025 Big Picture & Real-Time Stock Entry Alerts - Улправда
Portfolio Shifts: Will Intensity Therapeutics Inc. stock split attract more investorsPortfolio Return Report & Real-Time Buy Signal Notifications - Улправда
Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 News Drivers & AI Based Buy and Sell Signals - Улправда
Growth Review: What insider trading reveals about Intensity Therapeutics Inc. stockJuly 2025 Sector Moves & AI Based Trade Execution Alerts - DonanımHaber
Published on: 2025-12-19 09:02:42 - Улправда
Fundamentals Check: Can Intensity Therapeutics Inc. stock double in next 5 yearsWeekly Gains Report & Growth Focused Entry Reports - Улправда
Can Intensity Therapeutics Inc. stock resist sector downturns2025 Earnings Impact & Fast Gain Stock Tips - Улправда
Is Intensity Therapeutics Inc. stock supported by innovation pipelineDip Buying & Daily Volume Surge Trade Alerts - Улправда
Market Review: Why Intensity Therapeutics Inc. stock is a must watch in 2025IPO Watch & Verified Technical Signals - Улправда
MSN Money - MSN
Intensity Therapeutics to present two posters ay SABCS - MSN
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy - sharewise.com
All you need to know about Intensity Therapeutics Inc. (INTS) rating upgrade to buy - MSN
Immuron (IMRN) struggles after announcing trial results - MSN
Value Recap: Is Intensity Therapeutics Inc stock positioned for digital transformationJuly 2025 Snapshot & Technical Confirmation Trade Alerts - moha.gov.vn
Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium - PR Newswire
Intensity Therapeutics (Nasdaq: INTS) to present TNBC safety, Phase 3 design at SABCS - Stock Titan
What drives Intensity Therapeutics Inc stock priceTechnology Stock Trends & Explosive Profit Potential - earlytimes.in
Intensity Therapeutics reports Q3 EPS (6c) vs. (25c) last year - MSN
You might want to take a look at Intensity Therapeutics Inc (INTS) now - setenews.com
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - marketscreener.com
Intensity Therapeutics granted 180-day extension to regain Nasdaq compliance - MSN
INTS Stock Price and Chart — NASDAQ:INTS - TradingView
Update Report: How Intensity Therapeutics Inc stock benefits from global expansionPortfolio Gains Summary & AI Based Trade Execution Alerts - moha.gov.vn
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule - Investing.com Nigeria
Intensity Therapeutics Granted Nasdaq Compliance Extension - The Globe and Mail
Intensity Therapeutics stock rises after securing Nasdaq listing extension By Investing.com - Investing.com Nigeria
Intensity Therapeutics stock rises after securing Nasdaq listing extension - Investing.com
Intensity Therapeutics Gets Extension to Regain Nasdaq Minimum Price Requirement - marketscreener.com
Intensity Therapeutics granted 180-day extension - marketscreener.com
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule By Investing.com - Investing.com South Africa
Intensity Therapeutics jumps after Nasdaq grants compliance extension - TradingView — Track All Markets
Intensity Therapeutics, Inc. (INTS) 18.98% in Intraday Trading: Surge Ahead of Conference Presentations - Stocks Telegraph
Intensity Therapeutics expands at-the-market offering - MSN
Intensity Therapeutics files for offering of up to $30 million common stockSEC filing - marketscreener.com
Intensity Therapeutics expands at-the-market offering program to $30 million - Investing.com Australia
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):